Evaluation of Intravitreal Aflibercept for the Treatment of Severe Nonproliferative Diabetic Retinopathy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Ophthalmology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Evaluation of Intravitreal Aflibercept for the Treatment of Severe Nonproliferative Diabetic Retinopathy: Results From the PANORAMA Randomized Clinical Trial
JAMA Ophthalmol 2021 Aug 05;[EPub Ahead of Print], DM Brown, CC Wykoff, D Boyer, JS Heier, WL Clark, A Emanuelli, PM Higgins, M Singer, DM Weinreich, GD Yancopoulos, AJ Berliner, K Chu, K Reed, Y Cheng, R VittiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.